CDC investigating fake Botox injections, warns of fatal risks

This news has been read 467 times!

NEW YORK, April 13: The US Centers for Disease Control and Prevention (CDC) has launched an investigation into reports of several cases of botulism-like illnesses associated with botulinum toxin injections, commonly known as ‘Botox,’ administered outside of medical settings.

In a statement released on Friday, the CDC stated that it is coordinating a multi-state outbreak investigation following reports of these illnesses in several states. Collaborating with health departments in Tennessee and Illinois, as well as the Food and Drug Administration (FDA), the CDC aims to determine the source and extent of the issue.

Tennessee health officials reported four patients seeking medical attention after experiencing botulism-like symptoms after receiving Botox injections for cosmetic purposes. Among them, two individuals required hospitalization. Concerns have arisen regarding the use of potentially counterfeit products or products of uncertain origin administered in non-medical settings, such as homes or cosmetic spas.

Similarly, the Illinois Department of Public Health highlighted two cases where patients reported symptoms consistent with botulism after receiving potentially counterfeit Botox injections. Both patients, hospitalized as a result, received injections from a licensed nurse operating beyond her authorized scope.

Additional cases have emerged in Kentucky, Washington, and Colorado, prompting the CDC to underscore the unknown or unverified sources of these botulinum toxin products.

Botulism, a severe and potentially fatal illness, arises when a toxin attacks the body’s nerves, leading to symptoms such as muscle weakness, difficulty breathing, and blurred vision. Dr. Salar Hazany, a certified dermatologist, expressed particular concern over respiratory complications, noting the potential fatality associated with breathing difficulties.

Dr. Craig Lehrman, director of aesthetic surgery at The Ohio State University Wexner Medical Center, highlighted the prevalence of counterfeit Botox and its adverse effects. Stressing the importance of FDA-approved products administered by licensed providers in regulated settings, Lehrman warned against the serious risks posed by fraudulent or inadequately managed injections.

The CDC emphasized the importance of seeking FDA-approved cosmetic injections from licensed providers and cautioned against choosing providers solely based on cost. Despite the rarity of laboratory-confirmed cases of systemic botulism, experts urged individuals to prioritize safety when considering Botox injections.

As investigations continue, health officials urge anyone experiencing botulism-like symptoms following an injection to seek immediate medical attention, underscoring the gravity of the situation and the importance of vigilant healthcare practices.

This news has been read 467 times!